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During the highly regulated process of wound healing the 
expression of the interstitial collagens I and III is increased in 
a time-dependent fashion. Although ultrastructural and in 
vitro studies suggest a physiologic role of collagen VI in the 
organization of extracellular matrix deposition, nothing is 
known about its role in wound healing. Therefore, we stud-
ied collagen VI gene expression during wound healing in 
humans compared to that of collagens I and III. The presence 
of specific al (VI) and a3(VI) mRNA species in scar tissue 
was demonstrated by Northern blot analysis. Quantification 
of mRNA expression by dot blot analysis and in situ hybrid-
ization indicated that like for the interstitial collagens I and 
III collagen VI gene expression was increased during wound 
healing, reaching its maximum 2 weeks after initial insult. In 
W ound healing is a highly regulated event. The different phases include the infiltration by in-flammatory cells, the formation of granula-tion tissue and the deposition of connective tissue, which finally leads to the restoration of 
the normal architecture [1]. Previous studies have investigated the 
expression of the interstitial collagens type I and III during wound 
healing both at the protein and at the gene level [2-5]. Collagen 
gene expression appears to be regulated in a time-dependent fash-
ion. In the early phase of wound healing the expression of a1 (I) and 
al(III) collagen chains is coordinately increased throughout the 
entire dermis. In later stages the gene expression is rapidly down 
regulated, first in the lower dermis, and later also in the papillary 
dermis as well. In contrast, little is known about the role of type VI 
collagen in the process of wound healing. 
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the late phase of wound healing like al(l) the al(VI) gene 
expression was not down regulated significantly. In contrast, 
a reduction of a3(VI) collagen gene expression was observed, 
as was for the al(III) collagen gene, indicating a non-coor-
dinate regulation of these chains. Collagen VI gene expres-
sion could be localized to fibroblast-like cells and to endo-
thelial cells of newly formed vessels. Collagen VI gene 
expression was undetectable in smooth muscle cells and myo-
epithelial cells of eccrine glands. These results indicate that 
collagen VI gene expression is regulated in a time-dependent 
fashion and that fibroblasts and endothelial cells appear to 
play an important role in collagen VI synthesis during wound 
healing.] Invest DermatoI100:329-334, 1993 
Type VI collagen is a ubiquitous component of extracellular ma-
trices present in most connective tissues [6-8]. It is a heterotrimer 
composed of three polypeptide chains, a1(VI), a2(VI) and a3(VI), 
with molecular masses of approximately 140, 140, and 260 kDa, 
respectively [9,10]. Whereas the al(VI) and a2(VI) collagen genes 
are both located on chromosome 21, the a3(VI) collagen gene is 
located on chromosome 2 [11]. Major mRNA species encoding 
these chains have a size of 4.2 kb (a1), 3.5 kb (a2), and 8.5 kb (a3) 
[11] . In vitro experiments have indicated that mRNA expression of 
the constituent chains is differentially regulated and that the synthe-
sis of the a3(VI) chain appears to be the rate-limiting step for the 
productio~ of intact ~ollagen VI [12]. The monomer of type VI 
collagen IS charactenzed by a rather short triple helix (length 
105 nm) flanked on each side by large globular domains resulting in 
a dumbell-shaped appearance. These monomers have the potential 
to form disulfide-linked dimers and tetramers that are thought to 
represent the building blocks of tissue microfibrils [6] . 
The biologic functions of type VI collagen are not yet fully un-
derstood. Type VI collagen networks have been identified in the 
vicinity of interstitial collagen and basement membranes of nerves 
and blood vessels by immunoelectronmicroscopy suggesting that 
these type VI collagen micro fibrils may function as a mechanical 
link between these structures and the surrounding connective tis-
sues [13]. 
III vitro experiments have shown that pepsin-solubilized and in-
tact type VI collagen substrates mediate attachment and spreading of 
several cell types including fibroblasts [14]. Cell-attachment me-
diating properties have also been ascribed to a fusion protein con-
taining the collagenous domain of the a3(VI) chain [15]. 
Furthermore, recent studies have shown that the globular do-
mains of type VI collagen contain motifs similar to type A domains 
of von Willebrand factor, which have been shown to bind to extra-
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cellular matrix such as type I collagen, implying a possible bridging 
role of type VI coll agen with other matrix proteins in connective 
tissues [15 -17]. 
All of these findings suggest that type VI collagen may play an 
important role in the organization of a coordinate matrix deposition 
as is required for wound healing of primary intent. Therefore, the 
present study was designed to characterize the expression of colla-
gen VI mRN A species in comparison to that of the interstitial colla-
gens type I and III in wound healing. 
MATERIALS AND METHODS 
Preparation of Tissue Samples The study was performed on 
re-excision biopsy specimens obtained from patients 8,11,17,21, 
24, and 34 d after initial wounding for removal of a malignant 
melanoma. All wounds were healing by primary intention. Normal 
control skin was obtained from healthy volunteers. All these full-
thickness biopsies were obtained under local anesthesia after in-
formed consent. These tissue specimens were immediately snap 
frozen in liquid nitrogen and stored at - 80 °C until used. 
RNA Extraction and Analysis by Northern and Dot-Blot 
Hybridization Frozen biopsies were cut on dry ice into tiny sec-
tions and homogenized in 4 M guanidine-isothiocyanate contain-
ing 0.1 M 2-mercaptoethanol. After centrifugation at 14,000 rpm 
at 4°C for 15 min, supernatants were extracted with phenol (Serva, 
Heidelberg, Germany) and chloroform (J .T. Baker Chemicals 
B.V., Deventer, the N etherlands). RNA was then separated by ultra-
centrifugation through a 5.7 M cesium chloride cushion according 
to standard protocols [18]. For dot-blot analysis, serial dilutions of 
total RNA (2,1 , 0.5, and 0 ).Lg) were applied to nylon membranes 
(Gene Screen, DuPont, Boston) using a dot blot apparatus. For 
Northern blot analysis, total RNA [2).Lg per lane for al(I), al(III), 
and al (VI) and 20).Lg per lane for a3(VI)] was separated by gel 
electrophoresis on 1 % agarose gels under denaturing conditions and 
transferred onto nylon membranes by capillary blotting. After 
crosslin king of RNA to the filters by exposure to UV light they 
were pre-hybridized in 50% formamide, 0.1 % sodium dodecylsul-
fate (SDS) , 5 X sodium chloride, sodium citrate buffer (SSC), 5 X 
Denhardt's solution, and sonicated herring sperm DNA (100).Lg/ 
ml). Hybridization was carried out with eDNA probes that had been 
labeled with 32P_dATP by random priming to specific activities of 
2-5 X 108 cpm/).Lg (Amersham, UK) for 12 h at 42°C in the buffer 
described above. After hybridization filters were washed twice in 
2 X SSC, 0.1 % SDS at room temperature for 10 min, followed by 
stringent washing in 0.1 X sse, 0.1 % SDS at 42° Cor 65 ° C for 15 
min. Filters were then exposed to radiosensitive film (Kodak, x-
Omat AR) at - 80 °C. Relative amounts of RNA were measured by 
densitometry (Hirschmann Elscript 400) . Before rehybridization, 
filters were stripped in 0.1 X SSC, 0.1 X SDS at 90°C for 20 min. 
Inserts isolated from the plasmids Hf-677 with a 1.4-kb insert 
specific for the al(I) collagen chain [19], pIlI-33 with a 0.9-kb 
insert for the al(I1I) collagen chain [20], P18 with a 1.8-kb insert 
for the al(VI) collagen chain, P24 with a 1.8-kb insert for a3(VI) 
collagen [21], and D~-1 with a 264-bp insert for ~-tubulin [22] were 
used as hybridization probes. 
Preparation of cRNA Probes To generate cRNA probes for 
the detection of al and a3 type VI collagen chain mRN A species by 
in situ hybridization, fragments of the original cDNA clones P18 
[for al (VI)] and P24 [for a3(VI)] [21] were subcloned into Gem 3 
vector (Promega Biotec, Madison, USA) containing SP6 and T7 
RNA polymerase promoters on either side of the multiple cloning 
site. In brief, a 1.8-kb (1795-bp) fragment of the original cDNA 
clone P18 was excised by EcoRI, purified, and subsequently di-
gested with Kpnl. A resulting 461-bp fragment from the 5' end of 
the original eDNA corresponding to the sequence coding for a 
major portion of the al(VI) triple-helical domain was subcloned 
into Gem 3 vector that had been prepared by linearization with 
Kpnl foll owed by digestion with EcoR!. Similarly, a 1.8-kb (1787-
bp) EcoRI fragment of the original cDNA clone P24 was purified 
and submitted to digestion with Sma!. A resulting 726-bp fragment 
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Figure 1. Schematic representation of cDNA fragments encoding for 
human al(VI) and a3(VI) collagen mRNA. The triple-helical domains are 
depicted as ope/J boxes. The original cDNA clones P18 and P24 [21] were 
cleaved with appropriate restriction enzymes. The resulting fragments 
P18 sub (461 bp) and P24 sub (726 bp) encode a major portion of the 
al(Vl) triple-helical domain and a large portion of the C-terminal globu-
lar domain of the a3(Vl) chain, respectively. These cDNA fragments were 
subcloned into Gem 3 vector and used as templates for the generation of 
cRNA probes for ill situ hybridization. 
from the 3' end of the original eDNA clone P24, complementary to 
the sequence coding for a large portion of the C-terminal globular 
domain of the a3(VI) chain, was subcloned into the Smal/EcoRi 
site of Gem 3 vector (Fig 1) . 
The hybridization specificity of the probes thus generated using 
these subcloned cDNA fragments as templates to al(Vl) and 
a3(VI) collagen mRN A species was verified by Northern blot analy-
sis (data not shown) . cRNA probes for detection of mRNA foral(I) 
and al(I1I) collagen chain were described previously [3] . Following 
linearization with appropriate restriction enzymes, in vitro tran-
scription was carried out for 90 min at 37 ° C in the presence of 1 ).Lg 
DNA template, 10 mM dithiothreitol (OTT) (Sigma, St. Louis, 
MO), 20 U RNasin (Promega Biotec), 500 ).Lmol each ATP, GTP, 
CTP (Boehringer, Mannheim, FRG), 10 ).Lmol of unlabeled UTP, 
50 ).LCi of 35S_UTP (specific activity 1282 Ci/mmol; Amersham, 
UK), and 1).L1 (15-20 units) of SP6 or T7 polymerase (Promega 
Biotec). After digestion of the DNA templates with 2U of DNase I 
(Promega Biotec), RNA probes were extracted with phenol and 
chloroform, precipitated from 0.3 M sodium acetate with ethanol, 
and redissolved in 20 ).LI of water. 
In Situ Hybridization The protocol for ;n s;tII hybridization has 
been described elsewhere [3J . Briefly, 5-).Lm frozen sections 
mounted on slides were hybridized with al(Vl), a3(Vl), al(IIl), 
and al (I) anti-sense riboprobes. After hybridization, the slides were 
washed and treated with RNase to remove non-specific binding, 
washed again, and dried . Subsequently, slides were dipped into 
NTB2 emulsion (Kodak) and exposed for 1 to 2 weeks at 4 ° C. 
Slides were developed in 019 (Kodak) and sections were stained 
with hematoxylin. To check the integrity of tissue RNA and the 
specificity of the hybridization, a cRN A probe for human suprabasal 
keratin [23] was used as positive control, and sense cRNA probes for 
al(Vl), a3(Vl) collagen were used as negative controls. 
Combined Use of In Situ Hybridization and Immunohisto-
chemistry For use of in situ hybridization and immunostaining 
on the same section, the slides were treated after in situ hybridization 
as follows: after RNase treatment, the slides were washed in PBS 
and dried for 30 min at room temperature. The slides were then 
incubated for 1.5 h at room temperature with mouse antibodies 
diluted in Dulbecco's modified (DMEM) supplemented with 10% 
fetal bovine serum (FBS) against vimentin (1: 10) [24,25)' desmin 
(1 : 50) [24,25]' von Willebrand fac tor (1: 25) [26] (Dakopatts, 
Denmark), and a -smooth muscle actin (1 : 50) (kindly provided by 
Prof. G. Gabbiani) [27]. Slides were then incubated with peroxi-
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Figure 2. Northern blot analysis of total RNA extracted from scar tissue 
on day 14 after initial insult. After electrophoresis in 1 % agarose gels and 
transfer to nylon membranes, mRNAs were hybridized to labeled cDNA 
probes specific for 0'1(1), O'l(IlI), O'I(VI) and 0'3(VI). The 0'1(1) specific 
cDNA probe hybridized to two mRNA species with apparent sizes of 
7.2 kb and 5.9 kb. The O'l(Ill) specific cDNA probe hybridized to two 
mRNA species with apparent sizes of 6.6 kb and 5.8 kb. The O'I(VI) spe-
cific cDNA probe hybridized to one mRNA species with an apparent size 
of 4.2 kb, and the O'3(VI) specific cDNA probe hybridized to one mRNA 
species with an apparent size of 8.5 kb. The relative positions of 285 and 
185 ribosomal RNA are indicated by bars to the left of each lane. 
dase-conjugated rabbit anti-mouse immunoglobulin antibodies 
(1 : 100, Dakopatts Denmark) for 45 min at room temperature. 
Control experiments were performed using PBS instead of primary 
antibodies. The color reaction was produced using 3-amino-9-eth-
ylcarbazole in a final concentration of 0.008% in PBS for 40 min. 
The slides were dipped two times into distilled water, air dried, and 
submitted to autoradiography as described above. 
Quantitative Evaluation of rnRNA Expression by In Situ Hy-
bridization To chronologically compare the relative propor-
tions of fibroblasts displaying positive hybridization signals, six 
biopsies (obtained on days 8, 11, 17, 21, and 24 after initial opera-
tions, and normal control skin) were cut and mounted on the same 
slides. These slides were hybridized with 0'1 (1),0'1 (III), 0'1 (VI), and 
a3(VI) collagen cRNA probes respectively and exposed in parallel 
under identical conditions (1.5 X 106 cpm riboprobe/section for 1 
week). Five fields in each of the samples were randomly selected and 
all of the fibroblasts in each field were examined for the presence or 
absence of positive hybridization signals. Only fibroblasts with sig-
nals that were clearly above background were considered positive. 
RESULTS 
To identify the presence of specific mRNA species for the 0'1(1), 
0'1 (III), 0'1 (VI), and 0'3 (VI) collagen chains in scar tissue, Northern 
blot analysis was performed. Total RNA was isolated from wound 
biopsy specimens and from normal control skin, and separated by 
agarose gel electrophoresis as described, confirming that the RNA 
was intact. Subsequent hybridization with the corresponding la-
beled cDNA probes revealed the presence of characteristic mRNA 
species for 0'1(1), 0'1 (III), a1(VI), as well as a3(VI) collagen chains 
(Fig 2). 
In an attempt to quantify the chronologic development of 
mRNA expression for collagen VI in comparison to that of colla-
gens I and III during wound healing, dot blot analysis was per-
formed of total RNA isolated from normal control skin and speci-
mens obtained 8, 11, 14, and 34 d after initial insult (Fig 3). The 
expression of all mRNA species tested [0'1(1), a3(III), a1(VI) and 
a3(VI)] was increased during wound healing, reaching its maxi-
mum 2 weeks after the initial insult. After 14 d mRNA expression 
for the 0'1 (III) collagen and a3(VI) collagen chains started to de-
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Figure 3. Collagen VI mRNA expression during wound healing as a 
function of time after initial insult. The relative amounts of 0'1(1) (opell 
squares), 0'1(111) (closed squares), O'I(VI) (opw triatlgles) , 0'3(VI) (closed Iriatl-
gles) mRNA species were determined by dot blot analysis as described. 
Total RNA was isolated from scar tissues on days S, 11, 14, and 34 after 
initial operation. To eliminate differences due to unequal amounts of total 
RNA, the filters were stripped and rehybridized with a cDNA probe 
specific for ft-tubulin. The densitometry values of each collagen mRNA 
species were corrected for the levels of ft-tubuIin mRNA and expressed as 
arbitrary densitometry units. The expression of all four mRNA species 
evaluated increased until reaching its maximum on days 11 to 14. Thereaf-
ter, a decline of mRNA expression could only be observed for the 0'1 (III) 
and O'3(VI) chains. 
cline. In contrast, mRNA expression for the 0'1 (I) and 0'1 (VI) colla-
gen chains was still upregulated on day 34 after insult. 
. Attempts to quantif~ specific mRNAs by dot blot analysis of total 
tissue RNA. have the disadvantage of not allowing an estimation of 
the proportIOns of normal S~1n to actual wounded skin in the speci-
men, thus not allOWing a fair representation of changes in mRNA 
levels at the actual site of the lesion. Therefore, we also tried to 
~uantify loc~lized col.lagen mRNA expression by i" situ hybridiza-
tIOn as ~es~n.bed. ThiS al.lowed to assess mRNA expression at the 
I~vel of indiVidual cells, directly at the site of the lesion. The expres-
sion of mRNAs for type VI collagen and the interstitial collagens I 
and III was clearly dependent on the phase of wound healing (Fig 4). 
The number of cells expressing 0'1 (VI) and 0'3(VI) mRNA in-
~reased in. the early phase and reached a plateau 11 d after initial 
Insult. TIllS was paralleled by a similar increase in collagen I and III 
mRNA expression. In the later phase there was clear evidence for a 
discoordinat.e regulation of 0'1 (VI) and a3(VI) mRNA expression. 
The expression of a3(VI) mRNA started to decline after day 17. In 
contras~, no reduction from the plateau level of 0'1 (VI) mRNA 
expressIOn could be observed until day 24. In comparison, the num-
ber of cells displaying a positive signal for al(III) mRNA also 
started to decline after day 17, whereas that with a positive 0'1(1) 
mRNA signal remained at almost maximal levels throughout day 
24 (Fig 4). 
Itl situ hybridization also allowed determination of the localiza-
tion of cells expressing collagen VI mRNA during the different 
phases of wound healing (data not shown) . Until day 17, a simi lar 
distribution of cells yielding positive signals for a1(VI) and a3(VI), 
as well as 0'1(1) and 0'1 (III), mRNA was observed throughout the 
entire dermis at the incision site. Later on day 24, when 0'1 (III) and 
a3(VI) mRNA were down regulated again, fibroblast-like cells ex-
pressing 0'1 (1),0'1 (III), and 0'1 (VI) mRNA were concentrated more 
in the papillary dermis. The number of cells displaying a positive 
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Figure 4. Analysis of collagen VI mRNA expression as a function of time 
by in situ hybridization. Skin samples obtained on days 8, 11, 17, 21, and 
24 after initial injury and normal control skin were subjected to itl situ 
hybridization with each cRNA probe under identical conditions. The 
mean values of positive cells in each sample are expressed as a percentage 
of the total number of cells. The expression of al(I) (opetl squares), al(IIl) 
(closed squares), al(VI) (opm triatlgies), and a3(VI) mRNAs (closed triatlgies) 
all increased until reaching a plateau between days 11 and 17. Thereafter, 
only the expression of the al(III) and a3(VI) mRNAs decreased. 
signal for a3{VI) mRNA was lower than that expressing the other 
three mRNA species. At this stage a3{VI) mRNA expressing cells 
were mainly seen in the viciniry of newly formed blood vessels. 
It has been hypothesized that collagen-producing cells in the 
early phase of wound healing have characteristics of myofibroblasts 
(positive immunostaining for a-smooth muscle actin), a feature lost 
in the late stages of wound healing [28]. Therefore, we determined 
the phenorype of the cells expressing rype VI collagen, by combined 
application of immunostaining and in situ hybridization on the same 
section. Our findings are summarized in Table I and representative 
examples shown in Fig 5. Myoepithelial cells around eccrine glands 
stained positively with antibodies directed against a-smooth muscle 
actin. However, they did not express detectable levels of mRNA for 
collagen VI chains (Fig Sa). Smooth muscle cells in the dermis were 
positive for desmin, but did not show positive mRNA signals for the 
a1(VI) or the a3{VI) collagen chain either (Fig 5b). Positive a1{VI) 
and a3{VI) mRNA signals could only be detected in cells staining 
with antibodies directed against vimentin (Fig 5c), identifying these 
Table I. Distribution of Vim entin, Desmin, von Willebrand 
Factor, a-Smooth Muscle Actin, and Type VI Collagen mRNA 
Expression in Different Cell Types of Human Scar Tissue 
Vimentin Desmin vWF a-SMA al(VI) a3(VI) 
Fibroblasts + + + 
Endothelial + + + + 
cells 
Smooth muscle + + + 
cells 
Myoepithelial + + 
cell of ec-
crine glands 
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cells as normal fibroblasts. However·, vimentin positive fibroblasts 
displaying P?sitive mRNA signals for the al{VI) and the a3{VI) 
collagen chams were also found in close promixiry of smooth mus-
cle cells and nearby eccrine glands. 
Because endothelial cells have been reported to produce rype VI 
collagen [29]' we also performed immunostaining with an antibody 
against von Willebrand factor. Indeed, positive mRNA signals for 
collagen VI could be detected in endothelial cells of newly formed 
vessels in the healing wound (Fig 5d). 
DISCUSSION 
In this study we were able to demonstrate that rype VI collagen gene 
expression is increased in the early phase of wound healing in 
humans and that the expression of mRNA for different constituent 
chains appears to be regulated discoordinately. Type VI collagen 
mRNA species are expressed by fibroblast-like mesenchymal cells, 
but not myofibroblasts. In addition, endothelial cells of newly 
formed vessels express mRNA for rype VI collagen. 
Our data show that mRNA species for the collagen VI chains are 
abundant~y ~xpressed in the early phase of wound healing in a 
~anner snmlar to that of the interstitial collagens I and III. The 
mcreased gene expression of the latter two collagens in the early 
ph.ase of wound heal.ing .observed here confirms previous reports on 
pnmary :vound .he~lm~ m humans and rats [2 - 5 J. The time-depen-
dent regIOnal dlstnbutlon of a1(I) and a1{III) mRNA expressing 
cells could also be confirmed. Both the time-dependent, increased 
rype VI collagen gene expression as well as the regional distribution 
of mRNA expressing cells appeared to be analogous to that of the 
interstitial collagens. 
We could demonstrate that collagen VI mRNA is mainly ex-
pressed by fibroblastic cells. However, endothelial cells of newly 
formed vessels also yielded positive rype VI mRNA signals. These 
data are in agreement with studies describing increased collagen VI 
g~ne expression in keloid [30] and neurofibroma [29], as well as 
With the fact that collagen VI was first isolated from the vessel wall 
[31]. They also corroborate in vitro findings that fibroblasts and 
endothelial cells in monolayer culture produce collagen VI [32,33]. 
Collagen VI synthesis has also been demonstrated in cultured 
smooth muscle cells isolated from chick embryo and adult human 
vessels [3.4,35]. However, no collagen VI mRNA signal could be 
detected m smooth muscle cells of the dermis, neither within nor 
arou.n? ~he wound. This discrepancy could be explained by the low 
sensltlVlry of the assay or by the fact that cells may rapidly alter their 
phenory~e. under culture conditions [36 - 38]. 
In addition to collagen VI gene expressing endothelial cells of 
newly formed vessels, fibroblast-like cells expressing collagen VI 
mRNA were observed in immediate viciniry of these blood vessels. 
This observation implies the possibiliry that both endothelial cells as 
well as surro.unding fibroblasts contribute to the deposition of colla-
gen VI, wluch has been observed by immunoelectronmicroscopy 
near the basement membrane of vessel walls [13] . 
The finding that a3(VI) mRNA is down regulated during the 
later phase of wound healin~ whereas a1{VI) is still up regulated 
may be a reflection of the different chromosomal location of the 
genes for the .a1{VI) chain and the a3{VI) chain [11]. It is also in 
~ccord~n~e Wit? previous in vitro studies from our laboratory reveal-
mg a snn.Iiar dlscoordinate regulation of the different collagen VI 
a-chams m response to IF~-y treatment of cells [12]. In that particu-
lar study,. th.e.gene expressIOn for the a3(VI) chain appeared to be 
the rate-lnmtmg step for the overall collagen VI synthesis. In anal-
ogy, it may be ~ostulated that the observed down regulation of the 
a3{VI) mRNA m the later stage of wound healing may be sufficient 
for a down r~gulation of total collagen VI protein synthesis. 
Recently, It has been reported that the a3(VI) chain binds to 
collagen I [15] and that collagen VI has important cell-attachment 
prop~rtie.s [14] ,. i,:dicating a potential bridging function of collagen 
VI With l11terstltlal collagen fibers during the organization of con-
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Figure 5. Identification of the cell type expressing collagen VI mRNA by combined application of immunohistochemistry and ill situ hybridization. a 
shows a tissue specimen from day 11 after injury that was stained for a-smooth muscle actin and hybridized with the aI(VI) cRNA probe. Myoepithelial 
cells surrounding eccrine glands are identified by positive staining for a-smooth muscle ac~ (opel~ arrow). a1(VI) mRNA signal is present over 
fibroblast-like cells in the vicinity of eccrine glands (solid arrOlv), but not over a-smooth muscle actin posItive cells. b shows another section from the same 
specimen stained fordesmin and hybridized with the a1(VI) cRNA probe. S~ooth muscle c~lIs are clearly identified by positive staining for desmin (opell 
arrow). Fibroblast-like cells generating a positive mRNA signal are detected in th~ surr?un~gs of smooth muscle cells (solid arrow) , but the smooth cells 
themselves do not generate detectable signals for a1(VI) mRNA. ~ shows the Identifi~ation of fi?r~blasts beneath the epidermis (E) by staining for 
vimentin. An abundant autoradiographic signal for a1(VI) mRNA IS ~etected overlappmg the .ma)onty of vlffientin positive cells. d shows a specimen 
obtained on day 17 after insult, stained with an antibody against von Willebrand fa~tor and hybndized ~Ith a a1(VI) cRNA probe. Positive a1 (VI) mRNA 
signals were seen not only over fibroblast-like cells (opell arrow), but also over von Willebrand factor posItive endothelial cells (solid arrow) of newly formed 
vessels (V). (Bars, 100,um.) 
nective tissues [15]. Observations that collagen VI gene expression 
is increased in active fibrotic syndromes such as the eosinophilia 
myalgia syndrome [39] or systemic sclerosis [40], in addition to our 
observations of increased expression of collagen VI in the early 
phase of wound healing with subsequent down regulation during 
the later phase, provide further support for the hypothesis that this 
molecule may playa key role in matrix organization that merits 
further investigation . 
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